ABSTRACT
Background Working under pandemic conditions exposes health care workers (HCWs) to infection risk and psychological strain. Protecting the physical and psychological health of HCWs is a key priority. This study assessed the perceptions of European hospital HCWs of local infection prevention and control (IPC) procedures during the COVID-19 pandemic and the impact on their emotional wellbeing.
Methods We performed two rounds of an international cross-sectional survey, between 31 March and 17 April 2020 via existing research networks (round 1), and between 14 May and 31 August 2020 via online convenience sampling (round 2). Main outcome measures were (1) behavioural determinants of HCW adherence with IPC procedures, (2) WHO-5 Well-Being Index, a validated scale of 0-100 reflecting emotional wellbeing. The WHO-5 was interpreted as a score below or above 50 points, a cut-off score used in previous literature to screen for depression.
Results 2,289 HCWs (round 1: n=190, round 2: n=2,099) from 40 countries in Europe participated. Mean age of respondents was 42 (±11) years, 66% were female, 47% and 39% were medical doctors and nurses, respectively. 74% (n=1699) of HCWs were directly treating patients with COVID-19, of which 32% (n=527) reported they were fearful of caring for these patients. HCWs reported high levels of concern about COVID-19 infection risk to themselves (71%) and their family (82%) as a result of their job. 40% of HCWs considered that getting infected with COVID-19 was not within their control. This was more common among junior than senior HCWs (46% versus 38%, P value <.01). Sufficient COVID-19-specific IPC training, confidence in PPE use and institutional trust were positively associated with the feeling that becoming infected with COVID-19 was within their control. Female HCWs were more likely than males to report a WHO-5 score below 50 points (aOR 1.5 (95% confidence interval (CI) 1.2-1.8).
Conclusions In Europe, the COVID-19 pandemic has had a differential impact on those providing direct COVID-19 patient care, junior staff and women. Health facilities must be aware of these differential impacts, build trust and provide tailored support for this vital workforce during the current COVID-19 pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This manuscript is part of the output from RECOVER (Rapid European COVID-19 Emergency research Response), which has received funding from the EU Horizon 2020 research and innovation programme (grant agreement number 101003589). STC received additional funding from the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England (PHE). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health and Social Care, or PHE. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted in accordance with the EU GDPR (General Data Protection Regulation) and the principles of the Declaration of Helsinki [34]. The Medical Research Ethics Committee of the University Medical Center (UMC) Utrecht (study sponsor) waived the need for official approval by the UMC Utrecht Ethics Committee (IRB correspondence number 18-574C). Electronic individual informed consent for participation in this study was obtained at the beginning of the survey. Written information about the purpose of the survey and how the data were to be used was provided to respondents upfront. For round 1, all data were analysed and stored pseudonymised, in round 2 data collection was fully anonymous.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
A generic version of the protocol and survey tool of this study is freely available via the Research & Development COVID-19 Blueprint of the World Health Organization (WHO) to be used in different clinical settings globally. The dataset analysed during the current study is available from the corresponding author upon reasonable request.
LIST OF ABBREVIATIONS
- CI
- Confidence Interval
- COVID-19
- Coronavirus disease 2019
- HCW
- Health Care Worker
- IPC
- Infection prevention and Control
- MERS-CoV
- Middle East Respiratory Syndrome coronavirus
- OR
- Odds Ratio
- PPE
- Personal Protective Equipment
- SARS-CoV-2
- Severe Acute Respiratory Syndrome coronavirus 2
- TDF
- Theoretical Domains Framework
- WHO
- World Health Organization
